Enzymatic Assay for Rapid Measurement of Antiretroviral Drug Levels
- 6 April 2020
- journal article
- research article
- Published by American Chemical Society (ACS) in ACS Sensors
- Vol. 5 (4) , 952-959
Abstract
Poor adherence to pre-exposure prophylaxis (PrEP) and antiretroviral therapy (ART) can lead to human immunodeficiency virus (HIV) acquisition and emergence of drug-resistant infections, respectively. Measurement of antiviral drug levels provides objective adherence information that may help prevent adverse health outcomes. Gold-standard drug-level measurement by liquid chromatography/mass spectrometry is centralized, heavily instrumented, and expensive and is thus unsuitable and unavailable for routine use in clinical settings. We developed the REverSe TRanscrIptase Chain Termination (RESTRICT) assay as a rapid and accessible measurement of drug levels indicative of long-term adherence to PrEP and ART. The assay uses designer single-stranded DNA templates and intercalating fluorescent dyes to measure complementary DNA (cDNA) formation by reverse transcriptase in the presence of nucleotide reverse transcriptase inhibitor drugs. We optimized the RESTRICT assay using aqueous solutions of tenofovir diphosphate (TFV-DP), a metabolite that indicates long-term adherence to ART and PrEP, at concentrations over 2 orders of magnitude above and below the clinically relevant range. We used dilution in water as a simple sample preparation strategy to detect TFV-DP spiked into whole blood and accurately distinguished TFV-DP drug levels corresponding to low and high PrEP adherences. The RESTRICT assay is a fast and accessible test that could be useful for patients and clinicians to measure and improve ART and PrEP adherence.Keywords
Funding Information
- National Cancer Institute
- M.J. Murdock Charitable Trust
- National Institute of Diabetes and Digestive and Kidney Diseases
- National Heart, Lung, and Blood Institute
- National Institute of Allergy and Infectious Diseases (AI027757, R01AI136648, R21AI127200)
- National Institute of Child Health and Human Development
- National Institute of Biomedical Imaging and Bioengineering (R01EB022630)
- National Institute on Aging
- National Institute on Drug Abuse
- National Institute of Mental Health
- National Institute of General Medical Sciences
- Mistletoe Research Foundation
- Fred Hutch Center for AIDS Research, University of Washington
This publication has 50 references indexed in Scilit:
- Tenofovir, Emtricitabine, and Tenofovir Diphosphate in Dried Blood Spots for Determining Recent and Cumulative Drug ExposureAIDS Research and Human Retroviruses, 2013
- Adherence to Highly Active Antiretroviral Therapy (HAART): A Meta-AnalysisAIDS and Behavior, 2011
- Pharmacy Adherence Measures to Assess Adherence to Antiretroviral Therapy: Review of the Literature and Implications for Treatment MonitoringClinical Infectious Diseases, 2011
- Real-Time Adherence Monitoring for HIV Antiretroviral TherapyAIDS and Behavior, 2010
- Evidence and Possible Consequences of the Phosphorylation of Nucleoside Reverse Transcriptase Inhibitors in Human Red Blood CellsAntimicrobial Agents and Chemotherapy, 2007
- Self-Report Measures of Antiretroviral Therapy Adherence: A Review with Recommendations for HIV Research and Clinical ManagementAIDS and Behavior, 2006
- Adherence to MedicationNew England Journal of Medicine, 2005
- Tenofovir Disoproxil FumarateClinical Pharmacokinetics, 2004
- Enzymatic Assay for Measurement of Intracellular DXG Triphosphate Concentrations in Peripheral Blood Mononuclear Cells from Human Immunodeficiency Virus Type 1-Infected PatientsAntimicrobial Agents and Chemotherapy, 2003
- Development of Enzymatic Assays for Quantification of Intracellular Lamivudine and Carbovir Triphosphate Levels in Peripheral Blood Mononuclear Cells from Human Immunodeficiency Virus-Infected PatientsAntimicrobial Agents and Chemotherapy, 2002